Radius Health to Announce Third Quarter 2019 Financial Results and Host Webcast Conference Call on November 5, 2019

NEXT STORY
FDA Approves Myriad’s myChoice® CDx Test to Help Identify Women Eligible for Treatment with Zejula® in Late-line Ovarian Cancer
PREV STORY
Partners HealthCare Names Ravi Thadhani, M.D., M.P.H. Chief Academic Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Radius Health to Announce Third Quarter 2019 Financial Results and Host Webcast Conference Call on November 5, 2019

NEXT STORY
FDA Approves Myriad’s myChoice® CDx Test to Help Identify Women Eligible for Treatment with Zejula® in Late-line Ovarian Cancer
PREV STORY
Partners HealthCare Names Ravi Thadhani, M.D., M.P.H. Chief Academic Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CUPE paramedics welcome new PTSD Bill

TORONTO, ONTARIO--(Marketwired - Feb. 18, 2016) - The Ontario government introduced a bill on ...

author_avatar
NASDAQ Market News

Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic Transformation Initiatives

author_avatar
NASDAQ Market News

Takeda and TiGenix Enter into Licensing Agreement for Ex-U.S. rights to Cx601 for the Treatment of Complex Perianal Fistulas in Patients with Crohn’s Disease

OSAKA, Japan and LEUVEN, Belgium, July 5, 2016 (GLOBE NEWSWIRE) -- Takeda Pharmaceutical Company ...

author_avatar
NASDAQ Market News